An analysis of the economic and patient outcome impact of an integrated COPD service in east London.
AffiliationNHS City and Hackney Clinical Commissioning GroupRespiratory Medicine, Homerton University Hospital NHS Foundation TrustNorth East London
MetadataShow full item record
AbstractExacerbations of COPD carry a huge burden of morbidity and a significant economic impact. It has been shown that home care may be useful for exacerbations of COPD. This article presents a review of an integrated COPD service in east London. Hospital Episode Statistics, Public Health Mortality Files and clinical data were used to analyze differences in health care usage and COPD patient outcomes, including COPD assessment test (CAT) scores for a subsample, before and after the introduction of the integrated service. There was a significant (30%) reduction in the number of hospital bed days for COPD patients (P<0.05), alongside a significant increase in patients with only a short stay (0-1 days) in hospital (P<0.0001). There was a significant increase in the number of patients dying outside of hospital (a proxy for quality of end-of-life care) following introduction of the service (P=0.00015). Patients also reported a clinically significant improvement in CAT scores. A locally developed economic model shows that the economic benefits of the service (via impact on place of death and reduction in length of hospital stay) were almost equal to the cost of the service. The increase in proportion of short-stay admissions and the reduction in bed days suggest an impact of the service on early supported discharge and that this along with an improvement in patient clinical outcomes and in quality of end-of-life care shows that an exemplar integrated COPD service can provide benefits that equate to a nearly cost-neutral service.
CitationAn analysis of the economic and patient outcome impact of an integrated COPD service in east London. 2017, 12:1653-1662 Int J Chron Obstruct Pulmon Dis
JournalInternational Journal of Chronic Obstructive Pulmonary Disease
- Factors contributing to high-cost hospital care for patients with COPD.
- Authors: Mulpuru S, McKay J, Ronksley PE, Thavorn K, Kobewka DM, Forster AJ
- Issue date: 2017
- Rising total costs and mortality rates associated with admissions due to COPD exacerbations.
- Authors: Molinari N, Chanez P, Roche N, Ahmed E, Vachier I, Bourdin A
- Issue date: 2016 Nov 14
- Cost-effectiveness of the Aerobika* oscillating positive expiratory pressure device in the management of COPD exacerbations.
- Authors: Khoudigian-Sinani S, Kowal S, Suggett JA, Coppolo DP
- Issue date: 2017
- RECODE: design and baseline results of a cluster randomized trial on cost-effectiveness of integrated COPD management in primary care.
- Authors: Kruis AL, Boland MR, Schoonvelde CH, Assendelft WJ, Rutten-van Mölken MP, Gussekloo J, Tsiachristas A, Chavannes NH
- Issue date: 2013 Mar 23
- COPD management costs according to the frequency of COPD exacerbations in UK primary care.
- Authors: Punekar YS, Shukla A, Müllerova H
- Issue date: 2014